Home › Atherosclerosis › Indiana › Hammond
Atherosclerosis clinical trials in Hammond, IN
3 studies for Atherosclerosis are looking for participants at sites in and around Hammond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
RecruitingPhase 2
- Asha Clinical Research-Munster,Llc, Hammond
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Cardiovascular Research of Northwest Indiana LLC, Munster · 1 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Tinley Park · 15 mi away
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Orlando, FL8 studies
- Arlington, VA8 studies
- Hialeah, FL8 studies
- Durham, NC7 studies
- Memphis, TN7 studies
- Dallas, TX7 studies
- Miami, FL7 studies
- Las Vegas, NV7 studies
- Minneapolis, MN6 studies
Other studies in Hammond
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer10 studies
- Breast Cancer9 studies
- Heart Failure8 studies
- Colorectal Cancer5 studies
- Ovarian Cancer5 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Pancreatic Cancer4 studies
- High Blood Pressure4 studies
- Macular Degeneration4 studies
- COPD3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.